Hobbs Group Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-304
Closed -$158K 293
2024
Q3
$158K Hold
304
0.06% 158
2024
Q2
$165K Buy
+304
New +$161K 0.06% 152
2023
Q4
$120K Buy
+254
New +$117K 0.05% 148

Other funds holding ELV

Hobbs Group Advisors's ELV Position: Q4 2024 in Review

Hobbs Group Advisors sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 304 shares — an estimated $158K sold.

Hobbs Group Advisors first reported a position in ELV in Q4 2023 and held it in 3 quarters. The position peaked at $165K in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Hobbs Group Advisors reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Hobbs Group Advisors sold 304 Elevance Health shares in Q4 2024, an estimated $158K.
  • Hobbs Group Advisors first reported a position in Elevance Health in Q4 2023 and held it in 3 quarters.
  • Hobbs Group Advisors's Elevance Health position peaked at $165K in Q2 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Hobbs Group Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.